Vitality Watch

Dossier clinicaltrials observational 30-jul-2026
Human cohort, case-control, or epidemiological association

The Impact of Diabetes Remission on Aging

Key claim: A prospective Chinese real-world cohort will test whether type 2 diabetes remission slows epigenetic aging, primarily via DunedinPACE, versus non-remitters.

Abstract

This study is a real-world, prospective clinical cohort study. It will enroll Chinese patients with type 2 diabetes. The aim is to assess the changes in aging biomarkers, primarily DunedinPACE, from baseline to post-remission, and to compare these biomarkers between patients who achieve successful remission and those who do not.

Why this matters

A prospective Chinese real-world cohort will test whether type 2 diabetes remission slows epigenetic aging, primarily via DunedinPACE, versus non-remitters.

Source

Link

Briefing card

The Impact of Diabetes Remission on Aging
Stage: observational · clinicaltrials · 30-jul-2026

A prospective Chinese real-world cohort will test whether type 2 diabetes remission slows epigenetic aging, primarily via DunedinPACE, versus non-remitters.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07736040

build build 880 · 2bcef25 · 2026-11-18